Levocetirizina Ciclum (Levocetirizine Dihydrochloride)

• Levocetirizine is an antihistamine that targets H1‑mediated allergic pathways, providing relief in several allergic conditions.
• Allergic rhinitis: reduces nasal congestion, sneezing, and itching associated with seasonal or perennial allergens.
• Chronic idiopathic urticaria: alleviates hives and associated itching that persist without an identifiable trigger.
• Allergic conjunctivitis: diminishes eye redness, tearing, and itching caused by allergen exposure.

• Levocetirizine selectively binds to peripheral histamine H1 receptors, preventing histamine from activating these receptors on mast cells, basophils, and sensory nerves. By blocking the H1‑mediated signal transduction, it inhibits the vascular permeability, smooth‑muscle contraction, and sensory nerve stimulation that underlie the classic symptoms of allergic reactions. The drug’s high affinity and rapid onset allow effective symptom control after a single dose, while its limited ability to cross the blood‑brain barrier reduces central nervous system effects compared with first‑generation antihistamines.

Levocetirizine may cause adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Drowsiness: mild sedation or sleepiness, especially at treatment initiation.
• Dry mouth: reduced salivation leading to throat discomfort.
• Headache: transient cranial pain of varying intensity.
• Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects

• Angioedema: swelling of face, lips, tongue, or airway requiring urgent care.
• Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Anaphylaxis: rapid onset systemic allergic reaction that can be life‑threatening.
• Thrombocytopenia: marked reduction in platelet count, increasing bleeding risk.
• Hepatic dysfunction: elevated liver enzymes indicating possible liver injury.

Before prescribing Levocetirizine, clinicians should consider several precautionary measures to ensure safe use.

• Renal function assessment: dose adjustment may be required in severe renal impairment.
• Hepatic disease caution: use carefully in patients with liver dysfunction.
• Sedation monitoring: advise patients not to operate machinery if drowsy.
• Allergy history review: avoid in individuals with known hypersensitivity to levocetirizine.
• Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Levocetirizine can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid)

• Alcohol: may potentiate sedative effects, increasing drowsiness.
• Central nervous system depressants (e.g., benzodiazepines): additive sedation risk.

Moderate Interactions (Monitor Closely)

• Ketoconazole or other strong CYP3A4 inhibitors: may raise levocetirizine plasma concentrations.
• Ritonavir: can increase drug levels, requiring clinical observation.
• Theophylline: levocetirizine may reduce theophylline clearance, potentially altering its effect.